| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/14/2001 | US6274360 Conversion of compactin to pravastatin by Actinomadura |
| 08/14/2001 | US6274336 Producing three-dimensional structure of active site using computer program, displaying and superimposing three-dimensional representation of test compound onto active site, preparing test compound, and testing in biological assay |
| 08/14/2001 | US6274177 Preparing crude liquid from rhizomes of ginger by extraction with organic solvent or by distillation with steam; introducing to reverse phase chromatography column, and eluting column with water; removing eluents; extraction |
| 08/14/2001 | US6274175 Prolonged release of GM-CSF |
| 08/14/2001 | US6274173 Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
| 08/14/2001 | US6274172 Therapeutic effervescent compositions |
| 08/14/2001 | US6274171 Antidepressant; Side effect reduction of nausea and vomiting |
| 08/14/2001 | US6274165 Patch for controlled delivery of oestradiol or its pharmaceutically acceptable derivatives |
| 08/14/2001 | US6274161 Compositions containing creatine in suspension |
| 08/14/2001 | US6274160 Methods of use of histamine H2 agonists in treating dry eye |
| 08/14/2001 | US6274146 Biologically active phytogenous proteoglycan and a method of making thereof |
| 08/14/2001 | US6274145 To generate cytolytic t cells against abnormal cells; as markers for pathological or abnormal condition in diagnosis |
| 08/14/2001 | US6273260 Pharmaceutical packaging system |
| 08/14/2001 | US6273092 Methods for treating various eye disorders |
| 08/14/2001 | CA2248955C The use of fumaric acid derivatives |
| 08/14/2001 | CA2243570C Mixture of recombinant vaccinia vectors as polyenv vaccines for hiv |
| 08/14/2001 | CA2226406C Novel pyridone carboxylic acid derivatives |
| 08/14/2001 | CA2206824C Inhibitors of rotamase enzyme activity |
| 08/14/2001 | CA2198570C New derivatives of boronic acid, the process for producing said derivatives and the pharmaceutical compound that contain them |
| 08/14/2001 | CA2193310C 4-imidazolidinone compounds; process for preparing the same and pharmaceutical compositions containing them |
| 08/14/2001 | CA2187591C Novel tertiary heterocyclic amines; process for preparing them and pharmaceutical compositions containing them |
| 08/14/2001 | CA2180464C Enteral formula with ribo-nucleotides |
| 08/14/2001 | CA2168560C Substituted oxazine and thiazine oxazolidinone antimicrobials |
| 08/14/2001 | CA2159640C Second messenger cell signaling inhibitors |
| 08/14/2001 | CA2158484C Novel benzopyrane derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/14/2001 | CA2148380C 5-arylindole derivatives |
| 08/14/2001 | CA2129013C Pyridinecarboximidamide compounds and the use thereof |
| 08/14/2001 | CA2124083C Preparation of substituted piperidines |
| 08/14/2001 | CA2088778C Transdermal contraceptive formulations, methods and devices |
| 08/14/2001 | CA2083754C Stable vitamin and/or carotenoid products in powder form, and the preparation thereof |
| 08/14/2001 | CA2035179C Pharmaceutical compositions containing insoluble salts of bisphosphonic acids |
| 08/14/2001 | CA2029265C 4- and 6-carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments |
| 08/14/2001 | CA2014545C Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 08/14/2001 | CA2014390C Therapeutical compositions for the treatment or the prevention of snoring |
| 08/14/2001 | CA2012312C Genetic units for inhibiting the function of rna |
| 08/10/2001 | CA2331876A1 Water-soluble ligand-binding proteins and analogs of ligand-gated channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 08/09/2001 | WO2001057265A1 Methods and materials relating to metallocarboxypeptidase-like polypeptides and polynucleotides |
| 08/09/2001 | WO2001057261A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057205A1 Selective killing of cells by activation of double-stranded rna dependent protein kinase-pkr |
| 08/09/2001 | WO2001057189A2 Fas pathway genes |
| 08/09/2001 | WO2001057092A1 PROCESS FOR EXTRACTION OF β-GLUCAN FROM CEREALS AND PRODUCTS OBTAINED THEREFROM |
| 08/09/2001 | WO2001057078A1 Process for producing dialytic amyloid fiber polymerization nuclei, method of screening remedies for dialytic amyloidosis and remedies for dialytic amyloidosis |
| 08/09/2001 | WO2001057068A1 Mucin-1 derived antigens and their use in immunotherapy |
| 08/09/2001 | WO2001057061A1 Novel use of ribozymes to block gene expression |
| 08/09/2001 | WO2001057059A1 Antisense modulation of survivin expression |
| 08/09/2001 | WO2001057053A1 Method for preparing functionalised beta-(1,3)-glucan derivatives |
| 08/09/2001 | WO2001057045A1 Novel positive allosteric ampa receptor modulators (paarm), method for the production and use thereof as medicaments |
| 08/09/2001 | WO2001057042A2 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 08/09/2001 | WO2001057039A1 Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of the 5-ht7 receptor |
| 08/09/2001 | WO2001057037A1 Platelet adp receptor inhibitors |
| 08/09/2001 | WO2001057036A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057034A1 3-aminopyrazole inhibitors of cyclin dependent kinases |
| 08/09/2001 | WO2001057033A1 C10 carbamoyloxy substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001057032A1 C10 ester substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001057031A1 C10 carbonate substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001057030A1 C7 carbonate substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001057029A1 C7 heterosubstituted acetate taxanes as antitumor agents |
| 08/09/2001 | WO2001057028A1 C7 carbamoyloxy substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001057027A1 C7 ester substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001057026A1 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 08/09/2001 | WO2001057025A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057024A1 Blockade of voltage dependent sodium channels |
| 08/09/2001 | WO2001057023A1 Heterocyclic amide derivatives |
| 08/09/2001 | WO2001057022A2 Pyrazole compositions useful as inhibitors of erk |
| 08/09/2001 | WO2001057020A1 INDOLE AND BENZIMIDAZOLE INHIBITORS OF FACTOR Xa |
| 08/09/2001 | WO2001057015A1 INTERNAL 1,15-LACTONES OF FLUPROSTENOL AND RELATED PROSTAGLANDIN F2α ANALOGS AND THEIR USE IN THE TREATMENT OF GLAUCOMA AND INTRAOCULAR HYPERTENSION |
| 08/09/2001 | WO2001057008A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 08/09/2001 | WO2001057006A1 Thiazolidine carboxylic acid derivatives and their use in the treatment of cancer |
| 08/09/2001 | WO2001057002A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same |
| 08/09/2001 | WO2001056993A2 Pyrazole compositions useful as inhibitors of erk |
| 08/09/2001 | WO2001056992A2 Dibenzo (b,f) azepine intermediates |
| 08/09/2001 | WO2001056991A1 Substituted pyridine compounds useful for controlling chemical synaptic transmission |
| 08/09/2001 | WO2001056987A1 Tosylproline analogs as thymidylate synthase inhibitors |
| 08/09/2001 | WO2001056983A2 Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| 08/09/2001 | WO2001056981A1 Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives |
| 08/09/2001 | WO2001056959A1 A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
| 08/09/2001 | WO2001056610A1 Stabilised pharmaceutical compositions and process for their preparation comprising an antibiotic and an expectorant |
| 08/09/2001 | WO2001056609A1 Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments |
| 08/09/2001 | WO2001056607A1 Integrin expression inhibitors |
| 08/09/2001 | WO2001056592A1 Use of compounds for the regulation of food intake |
| 08/09/2001 | WO2001056583A1 Medicine containing anemonin as effective component for treating aseptic inflammation |
| 08/09/2001 | WO2001056581A1 Powdered preparation for inhalation and powder inhalant containing the same packed |
| 08/09/2001 | WO2001056580A1 Compositions of polygonum odoratum for prevention and treatment of disease |
| 08/09/2001 | WO2001056579A1 Methods for treating alzheimer's disease |
| 08/09/2001 | WO2001056578A1 Use of rofleponide in the treatment of irritable bowel syndrome (ibs) |
| 08/09/2001 | WO2001056577A1 Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices |
| 08/09/2001 | WO2001056576A1 Transdermal therapeutic system for the administration of zaleplon |
| 08/09/2001 | WO2001056575A1 Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid |
| 08/09/2001 | WO2001056574A1 Use of desloratadine for treating allergic and inflammatory conditions |
| 08/09/2001 | WO2001056573A1 Use of cox-2 inhibitors as gastroprokinetics |
| 08/09/2001 | WO2001056572A1 Compositions and methods for promoting healthy joints |
| 08/09/2001 | WO2001056571A1 Treating allergic and inflammatory conditions |
| 08/09/2001 | WO2001056570A1 Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives |
| 08/09/2001 | WO2001056569A1 Remedies or preventives for liver diseases containing diaminotrifluoromethylpyridine derivatives |
| 08/09/2001 | WO2001056568A1 Remedies or preventives for digestive diseases containing diaminotrifluoromethylpyridine derivatives |
| 08/09/2001 | WO2001056566A1 Neovascularization inhibitory compositions and method of inhibiting neovascularization |
| 08/09/2001 | WO2001056565A1 C-4 carbonate taxanes |
| 08/09/2001 | WO2001056564A1 C10 heterosubstituted acetate taxanes as antitumor agents |
| 08/09/2001 | WO2001056563A1 Adamantyl derivatives as anti-cancer agents |
| 08/09/2001 | WO2001056562A1 Stable emulsion compositions |